Dulac Edward J III
EVP, Chief Financial Officer
CIK: 1821530
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | Intellia Therapeutics, Inc. (NTLA) | S | 6,379 | $9.21 | $58,750.59 | View Details Filing |
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | Intellia Therapeutics, Inc. (NTLA) | S | 6,379 | $9.21 | $58,750.59 | View Details Filing |